BACKGROUND: Total joint replacement (TJR) is increasingly performed in older patients with more comorbidities, who are considered at higher risk for postoperative complications. We aimed to identify and calculate the odds ratio of the risk factors for infection, revision and death 3 months and 1 year after TJR as well as for postoperative blood transfusion and longer hospital stay. METHODS: We analyzed all primary total hip arthroplasty (THA) and total knee arthroplasty (TKA) cases in Nova Scotia between Apr. 1, 2000, and Mar. 31, 2014, as identified from the Discharge Abstract Database. We used the Charlson Comorbidity Index as a surrogate measure of comorbidities. We used hospital and physician billings data and Nova Scotia Vital Statistics data to identify the postoperative events in this cohort. RESULTS: A total of 10 123 primary THA and 17 243 primary TKA procedures were performed during the study period. The mean patient age was 66.1 (standard deviation 11.7) years and 67.1 (standard deviation 9.3) years, respectively. With THA, the risk of infection was higher in patients with heart failure and those with diabetes. For TKA, liver disease and blood transfusion were associated with a higher risk of infection. Revision rates were higher among patients with hypertension and those with paraparesis/hemiparesis for THA, and among patients with metastatic disease for TKA. Significant risk factors for death included metastatic disease, older age, heart failure, myocardial infarction, dementia, rheumatologic disease, renal disease, blood transfusion and cancer. Multiple medical comorbidities and older age were associated with higher rates of blood transfusion and longer hospital stay. CONCLUSION: We have identified the risk factors associated with higher rates of postoperative complications and longer hospital stay after TJR. The results enable individualized risk stratification during the preoperative consultation.
BACKGROUND: Total joint replacement (TJR) is increasingly performed in older patients with more comorbidities, who are considered at higher risk for postoperative complications. We aimed to identify and calculate the odds ratio of the risk factors for infection, revision and death 3 months and 1 year after TJR as well as for postoperative blood transfusion and longer hospital stay. METHODS: We analyzed all primary total hip arthroplasty (THA) and total knee arthroplasty (TKA) cases in Nova Scotia between Apr. 1, 2000, and Mar. 31, 2014, as identified from the Discharge Abstract Database. We used the Charlson Comorbidity Index as a surrogate measure of comorbidities. We used hospital and physician billings data and Nova Scotia Vital Statistics data to identify the postoperative events in this cohort. RESULTS: A total of 10 123 primary THA and 17 243 primary TKA procedures were performed during the study period. The mean patient age was 66.1 (standard deviation 11.7) years and 67.1 (standard deviation 9.3) years, respectively. With THA, the risk of infection was higher in patients with heart failure and those with diabetes. For TKA, liver disease and blood transfusion were associated with a higher risk of infection. Revision rates were higher among patients with hypertension and those with paraparesis/hemiparesis for THA, and among patients with metastatic disease for TKA. Significant risk factors for death included metastatic disease, older age, heart failure, myocardial infarction, dementia, rheumatologic disease, renal disease, blood transfusion and cancer. Multiple medical comorbidities and older age were associated with higher rates of blood transfusion and longer hospital stay. CONCLUSION: We have identified the risk factors associated with higher rates of postoperative complications and longer hospital stay after TJR. The results enable individualized risk stratification during the preoperative consultation.
Authors: Erik T Newman; Tyler Steven Watters; John S Lewis; Jason M Jennings; Samuel S Wellman; David E Attarian; Stuart A Grant; Cynthia L Green; Thomas P Vail; Michael P Bolognesi Journal: J Bone Joint Surg Am Date: 2014-02-19 Impact factor: 5.284
Authors: Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan Journal: Epidemiology Date: 2010-01 Impact factor: 4.822
Authors: Ana M Oviedo Baena; Susan M Moeschler; Hugh M Smith; Christopher M Duncan; Darrell R Schroeder; Sandra L Kopp Journal: J Clin Anesth Date: 2015-09-01 Impact factor: 9.452
Authors: Jason S Pruzansky; Michael J Bronson; Ronald P Grelsamer; Elton Strauss; Calin S Moucha Journal: J Arthroplasty Date: 2013-07-24 Impact factor: 4.757
Authors: Kimona Issa; Matthew R Boylan; Qais Naziri; Dean C Perfetti; Aditya V Maheshwari; Michael A Mont Journal: J Bone Joint Surg Am Date: 2015-12-02 Impact factor: 5.284
Authors: John P Meehan; Beate Danielsen; Sunny H Kim; Amir A Jamali; Richard H White Journal: J Bone Joint Surg Am Date: 2014-04-02 Impact factor: 5.284
Authors: Szilárd Nemes; Ola Rolfson; Annette W-Dahl; Göran Garellick; Martin Sundberg; Johan Kärrholm; Otto Robertsson Journal: Acta Orthop Date: 2015-03-25 Impact factor: 3.717
Authors: Ryan J O'Rourke; Anthony J Milto; Brian P Kurcz; Steven L Scaife; D Gordon Allan; Youssef El Bitar Journal: Knee Surg Sports Traumatol Arthrosc Date: 2022-04-13 Impact factor: 4.342
Authors: Sophia-Marlene Busch; Mustafa Citak; Mustafa Akkaya; Felix Prange; Thorsten Gehrke; Philip Linke Journal: Int Orthop Date: 2021-09-30 Impact factor: 3.075
Authors: Mikko S Venäläinen; Valtteri J Panula; Riku Klén; Jaason J Haapakoski; Antti P Eskelinen; Mikko J Manninen; Jukka S Kettunen; Ari-Pekka Puhto; Anna I Vasara; Keijo T Mäkelä; Laura L Elo Journal: JB JS Open Access Date: 2021-01-25